A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera Phys Sportsmed. 2011 Sep;39(3):83-93
A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera Phys Sportsmed. 2011 Sep;39(3):83-93
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD…
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment…
A. Espay, J. Giuffrida, Robert Chen, Jennifer E. Vaughan, Andrew P. Duker, D. Heldman Presented at the 2009 World Federation of Neurology World Congress on Parkinson’s Disease and Related Disorders
VIEW PRESS RELEASE [PDF] CLEVELAND, Ohio (January 28, 2009) – Cleveland Medical Devices Inc. (CleveMed) has launched a large scale multicenter clinical study to continue development and validation of Kinesia™, a compact wireless system for monitoring severity of Parkinson’s disease…
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment…
D. Heldman, Ph.D., David E. Riley, M.D., Brian N. Maddux, M.D., Ph.D.,J. Giuffrida, Ph.D. Presented at the 2008 American Academy of Neurology Annual Meeting
VIEW PRESS RELEASE [PDF] Palo Alto, Calif. – March 12, 2008 – Based on its recent analysis of the mobility disorder monitoring systems market, Frost & Sullivan recognizes Cleveland Medical Devices Inc. (CleveMed) with the 2008 North American Product Innovation…